• CLK2 Drives Platinum Resistance in Ovarian Cancer via BRCA1

  2026-05-19

  The reference study reveals that Cdc2-like kinase 2 (CLK2) is upregulated in ovarian cancer and confers platinum resistance by phosphorylating BRCA1, enhancing DNA repair. These insights provide a mechanistic basis for targeting CLK2 to overcome chemotherapy resistance, with significant implications for improving ovarian cancer treatment outcomes.

• Ibrexafungerp Retains Potent Activity Against Vaginal Candid

  2026-05-19

  This study demonstrates that ibrexafungerp (MK 3118) maintains potent in vitro antifungal activity against both fluconazole-susceptible and -resistant vaginal Candida isolates at acidic pH, closely mirroring the vaginal environment in vulvovaginal candidiasis (VVC). The findings highlight ibrexafungerp’s unique suitability for treating VVC, especially in cases where azole resistance limits therapeutic options.

• MALAT1/miR-125b/STAT3 Axis Regulates PCT Expression in Sepsi

  2026-05-18

  This study uncovers a mechanistic link between the long noncoding RNA MALAT1, miR-125b, and STAT3 signaling in regulating procalcitonin (PCT) expression in sepsis. By elucidating the MALAT1-mediated ceRNA network's influence on STAT3 and PCT, the work refines our understanding of sepsis biomarkers and highlights potential molecular targets for improved diagnostic and therapeutic approaches.

• Gepotidacin (GSK2140944): Transforming Antibacterial Researc

  2026-05-18

  Gepotidacin (GSK2140944) offers a first-in-class solution for combating antibiotic resistance, with a unique mode of action targeting bacterial type II topoisomerases. This article guides experimentalists through optimized workflows, troubleshooting, and advanced applications to maximize reproducibility and impact in antibacterial research.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Proto

  2026-05-17

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents proteolytic degradation during protein extraction and sample preparation, especially in workflows where EDTA could interfere with divalent cation-dependent assays. It is not suitable for protocols where metalloprotease inhibition via chelation is required, as it lacks EDTA.

• Evaluating Protease Inhibitor Libraries for SARS-CoV-2 Drug

  2026-05-16

  This review analyzes the design and utility of commercial protease inhibitor libraries for virtual screening and drug design, specifically in the context of SARS-CoV-2. The paper highlights gaps in design transparency, documentation, and compound diversity, impacting the reliability of these resources for high-throughput drug discovery.

• Rotavirus-Induced Downregulation of Nrf2: Mechanisms and Imp

  2026-05-15

  This study delineates how progressive rotavirus infection actively suppresses the redox-sensitive transcription factor Nrf2 and its downstream cytoprotective genes, highlighting a viral strategy to undermine host antioxidant defenses. The findings provide a mechanistic foundation for exploring Nrf2-modulating interventions in viral pathogenesis and cellular stress research.

• Fluorescein TSA Fluorescence System Kit: Amplifying Sensitiv

  2026-05-15

  The Fluorescein TSA Fluorescence System Kit delivers unrivaled sensitivity for detecting low-abundance targets in fixed cells and tissues via robust tyramide signal amplification. This article unpacks experimental workflows, real-world troubleshooting, and key innovations—translating reference study insights into actionable protocol enhancements for modern immunohistochemistry, immunocytochemistry, and in situ hybridization.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-05-14

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, minimally toxic fluorescent labeling of cell membrane lipid regions for cell tracing and proliferation detection in vitro and in vivo. It should not be used for intracellular or non-membrane labeling applications. This kit is best suited for studies requiring long-term membrane fluorescence and reliable tracking of cell division.

• TNF-alpha Recombinant Murine Protein: Applied Cell Death Res

  2026-05-14

  Harness TNF-alpha recombinant murine protein for precise apoptosis and inflammation modeling—now with new insights from transcription-independent cell death pathways. This guide details stepwise protocols, optimization strategies, and cutting-edge applications, leveraging both classic and emerging mechanistic frameworks.

• Epalrestat in Cancer Fructose Metabolism: Next-Gen Polyol Pa

  2026-05-13

  Explore how Epalrestat, a leading aldose reductase inhibitor, is transforming oxidative stress and cancer metabolism research by precisely targeting the polyol pathway. This article uniquely bridges cutting-edge findings in fructose metabolism with advanced assay considerations.

• Paroxetine Mesylate Inhibits MET/ERBB3 in Colorectal Cancer

  2026-05-13

  The referenced study demonstrates that Paroxetine Mesylate, a selective serotonin reuptake inhibitor, exhibits potent anticancer effects in human colorectal cancer cells by targeting the receptor tyrosine kinases MET and ERBB3. This work highlights the promise of drug repurposing in oncology and provides mechanistic insight into multi-targeted cancer therapy.

• Dual-Action Kinase Inhibitors Shape p38α MAPK Dephosphorylat

  2026-05-12

  This study uncovers that select kinase inhibitors not only block p38α MAPK activity but also accelerate its dephosphorylation by stabilizing a conformation preferred by phosphatases. These findings provide a mechanistic basis for designing dual-action inhibitors with improved specificity, offering new opportunities in inflammation and apoptosis research.

• Androgen Receptor and ARv7 in TNBC: Prognostic Impact and EP

  2026-05-12

  This study delineates the prognostic significance of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC), demonstrating that their expression correlates with poor outcomes and increased metastasis. The research highlights that targeted inhibition using EPI-001 suppresses metastatic and epithelial–mesenchymal transition (EMT) markers in TNBC models, suggesting novel intervention strategies for AR-driven breast cancer.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Workflow Mastery

  2026-05-11

  Accelerate apoptosis detection with the One-step TUNEL Cy5 Apoptosis Detection Kit, offering unmatched sensitivity and streamlined protocols for both tissue sections and cultured cells. Explore advanced troubleshooting, protocol enhancements, and translational research strategies rooted in the latest immune-metabolic discoveries.

16066 records 1/1072 page Next 12345 下5页 Last page